OOIR: Observatory of International Research

Papers

(The median citation count of Current Hypertension Reports is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Sex Differences in the Prevalence, Outcomes and Management of Hypertension	85
Gut Microbiota-Derived Short-Chain Fatty Acids Facilitate Microbiota:Host Cross talk and Modulate Obesity and Hypertension	53
The Effect of Alcohol on Blood Pressure and Hypertension	52
Machine Learning for Hypertension Prediction: a Systematic Review	50
Multiple Gestations and Hypertensive Disorders of Pregnancy: What Do We Know?	44
Coffee and Arterial Hypertension	35
Obstructive Sleep Apnea and Hypertension: Updates to a Critical Relationship	35
Sodium Intake and Risk of Hypertension: A Systematic Review and Dose–Response Meta-analysis of Observational Cohort Studies	33
Anxiety, Depression, and Pain: Considerations in the Treatment of Patients with Uncontrolled Hypertension	33
Interleukin 17A: Key Player in the Pathogenesis of Hypertension and a Potential Therapeutic Target	29
Periodontitis, Blood Pressure, and the Risk and Control of Arterial Hypertension: Epidemiological, Clinical, and Pathophysiological Aspects—Review of the Literature and Clinical Trials	29
The Burden of Resistant Hypertension Across the World	28
The Serotonin-Immune Axis in Preeclampsia	27
Blood Pressure Management in Acute Ischemic Stroke	25
Migrating Populations and Health: Risk Factors for Cardiovascular Disease and Metabolic Syndrome	24
How Dietary Fibre, Acting via the Gut Microbiome, Lowers Blood Pressure	24
An Update on Refractory Hypertension	22
Mitochondrial Dysfunction in the Pathogenesis of Preeclampsia	21
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation	20
Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease	19
Hypoxia-Inducible Factor 1 and Preeclampsia: A New Perspective	19
Electronic Cigarette Use and Blood Pressure Endpoints: a Systematic Review	19
Long-term Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rate in the Middle East and North Africa: a Systematic Review and Meta-analysis of 178 Population-Based Studies	18
The Role of Gut Microbiota in Hypertension Pathogenesis and the Efficacy of Antihypertensive Drugs	17
ACE-Inhibitors in Hypertension: A Historical Perspective and Current Insights	17

Racial Disparities in Diagnosis, Management, and Outcomes in Preeclampsia	16
The Effects of Pain and Analgesic Medications on Blood Pressure	15
Drug Interactions with Antihypertensives	14
The Influence of Gut Microbiota on the Cardiovascular System Under Conditions of Obesity and Chronic Stress	14
Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection	14
Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition	13
Lipoprotein (a) and Hypertension	13
The Time to Reconsider Mineralocorticoid Receptor Blocking Strategy: Arrival of Nonsteroidal Mineralocorticoid Receptor Blockers	13
Hypertension, Obesity, and COVID-19: a Collision of Pandemics	13
Use of Self-Measured Blood Pressure Monitoring to Improve Hypertension Equity	12
Integrating Measures of Myocardial Fibrosis in the Transition from Hypertensive Heart Disease to Heart Failure	12
Combined Oral Contraceptive Pill-Induced Hypertension and Hypertensive Disorders of Pregnancy: Shared Mechanisms and Clinical Similarities	12
Effects of Hypertension on Alzheimer’s Disease and Related Disorders	12
Hypertension Across a Woman’s Life Cycle	12
Systemic Hypertension in Infants with Bronchopulmonary Dysplasia	12
High Prevalence of Autonomous Aldosterone Production in Hypertension: How to Identify and Treat It	11
Strategies to Improve Adherence to Anti-Hypertensive Medications: a Narrative Review	11
Metabolic Syndrome Among American Indian and Alaska Native Populations: Implications for Cardiovascular Health	11
A Critical Role for the Paraventricular Nucleus of the Hypothalamus in the Regulation of the Volume Reflex in Normal and Various Cardiovascular Disease States	11
Hypertension in Pheochromocytoma and Paraganglioma: Evaluation and Management in Pediatric Patients	11
Implementing Hypertension Management Interventions in Immigrant Communities in the U.S.: a Narrative Review of Recent Developments and Suggestions for Programmatic Efforts	11
Advances in the Pathophysiology and Management of Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension	11
Myocardial Strain Imaging in Resistant Hypertension	10
The Association of Tuberculosis Mono-infection and Tuberculosis-Human Immunodeficiency Virus (TB-HIV) Co-infection in the Pathogenesis of Hypertensive Disorders of Pregnancy	10
Sox6, A Potential Target for MicroRNAs in Cardiometabolic Disease	10
Cardiovascular Disease Risk Reduction and Body Mass Index	10
Gut Microbiome over a Lifetime and the Association with Hypertension	10
Inverse Salt Sensitivity of Blood Pressure: Mechanisms and Potential Relevance for Prevention of Cardiovascular Disease	10
Metabolic Syndrome and Cardiac Remodeling Due to Mitochondrial Oxidative Stress Involving Gliflozins and Sirtuins	10
Antihypertensive Deprescribing in Older Adults: a Practical Guide	10
The Involvement of MicroRNAs in SARS-CoV-2 Infection Comorbid with HIV-Associated Preeclampsia	9
Isometric Resistance Training to Manage Hypertension: Systematic Review and Meta-analysis	9
Plant-Based Diets Reduce Blood Pressure: A Systematic Review of Recent Evidence	9
Management of Hypertension and Blood Pressure Dysregulation in Patients with Parkinson’s Disease—a Systematic Review	9
Addressing Hypertension Outcomes Using Telehealth and Population Health Managers: Adaptations and Implementation Considerations	8
WNT/β-catenin Pathway: a Possible Link Between Hypertension and Alzheimer’s Disease	8
Does Excess Tissue Sodium Storage Regulate Blood Pressure?	8
Effect of Different Classes of Antihypertensive Drugs on Arterial Stiffness	8
Maternal Hypertensive Pregnancy Disorders and Mental and Behavioral Disorders in the Offspring: a Review	8
The COVID-19 Pandemic: an Appraisal of its Impact on Human Immunodeficiency Virus Infection and Pre-Eclampsia	8
T Cell Immunometabolism and Redox Signaling in Hypertension	8
Comparison Between Automated Office Blood Pressure Measurements and Manual Office Blood Pressure Measurements—Implications in Individual Patients: a Systematic Review and Meta-analysis	8
Blood Pressure Reduction in Hypertensive Acute Heart Failure	8
Neurogenic Background for Emotional Stress-Associated Hypertension	7
Cardiovascular Dysfunction in Intrauterine Growth Restriction	7
Antenatal Programming of Hypertension: Paradigms, Paradoxes, and How We Move Forward	7
New Insights into the Critical Importance of Intratubular Na+/H+ Exchanger 3 and Its Potential Therapeutic Implications in Hypertension	7
Update on Treatment of Hypertension After Renal Transplantation	7
Newer Drugs to Reduce High Blood Pressure and Mitigate Hypertensive Target Organ Damage	7
Inflammation, Lymphatics, and Cardiovascular Disease: Amplification by Chronic Kidney Disease	7

Current Updates on Pre-eclampsia: Maternal and Foetal Cardiovascular Diseases Predilection, Science or Myth?	7
Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the Gut-Liver Axis	7
Epigenetic Mechanisms Involved in Inflammaging-Associated Hypertension	7
Physiological Mechanisms of Hypertension and Cardiovascular Disease in End-Stage Kidney Disease	6
Immune Cell Activation in Obesity and Cardiovascular Disease	6
Sexual Dimorphic Interplays Between Gut Microbiota and Antihypertensive Drugs	6
Refractory Hypertension: a Narrative Systematic Review with Emphasis on Prognosis	6
Arterial Stiffness and the Canonical WNT/β-catenin Pathway	6
Gut Microbiota and Its Role in the Brain-Gut-Kidney Axis in Hypertension	6
Uric Acid, Hypertensive Phenotypes, and Organ Damage: Data from the Pamela Study	6
Non-Dipping Blood Pressure or Nocturnal Hypertension: Does One Matter More?	5
Sympathetic Neural Mechanisms in Hypertension: Recent Insights	5
Hyperuricemia: An Intriguing Connection to Metabolic Syndrome, Diabetes, Kidney Disease, and Hypertension	5
Pet Ownership and the Risk of Arterial Hypertension and Cardiovascular Disease	5
Salt Taste and Salt Sensitive Hypertension in HIV	5
A Systematic Review of the Role of Telemedicine in Blood Pressure Control: Focus on Patient Engagement	5
Time-Restricted Eating in Metabolic Syndrome–Focus on Blood Pressure Outcomes	5
Recent Advances in Association Between Vitamin D Levels and Cardiovascular Disorders	5
Resistant Hypertension: Disease Burden and Emerging Treatment Options	5
The Renin-Angiotensin System, Hypertension, and SARS-CoV-2 Infection: a Review	5
Ambulatory Blood Pressure Monitoring in Pediatrics, an Update on Interpretation and Classification of Hypertension Phenotypes	5
Hypertension in Kidney Transplant Recipients: Where Are We Today?	5
Effects of Puberty on Blood Pressure Trajectories — Underlying Processes	4
Salt and Gut Microbiota in Heart Failure	4
Irregularities of Coagulation in Hypertension	4
Hypertension in Children and Adolescents with Turner Syndrome (TS), Neurofibromatosis 1 (NF1), and Williams Syndrome (WS)	4
Blood Pressure Effects of SGLT2 Inhibitors: Mechanisms and Clinical Evidence in Different Populations	4
Is Vitamin D Supplementation an Effective Treatment for Hypertension?	4
HEARTS in the Americas: Targeting Health System Change to Improve Population Hypertension Control	4
Hypertensive Disorders of Pregnancy and Heart Failure Risk	4
Blood Pressure Variability and Cognitive Function: a Scoping Review	4
Beta-Blockers in Pregnancy: Clinical Update	4
Strategies to Improve Medication Adherence and Blood Pressure Among Racial/Ethnic Minority Populations: A Scoping Review of the Literature from 2017 to 2021	4
Masked Hypertension in Healthy Children and Adolescents: Who Should Be Screened?	4
Preeclampsia and COVID-19: the Role of Inflammasome Activation	4
Dual Endothelin Antagonism with Aprocitentan as a Novel Therapeutic Approach for Resistant Hypertension	4
Novel Targets for Hypertension Drug Discovery	4
Angiotensin Receptor Blockers and Cognition: a Scoping Review	4
Pressure Building Against the Clock: The Impact of Circadian Misalignment on Blood Pressure	4